无法在这个位置找到： ”baidu_js_push.htm”
今日热点推荐：
爱地那非是什么？悦康“爱力士”
加入收藏 | 设为首页 | 热门搜索 |
网站地图
让患者参与到药品监管中：EMA与FDA的有益经验(4)
2020-02-14 未知 admin
[3] FDA. FDA Basics. Retrieved Oct 3, 2019 from https://www.fda.gov/about-fda/transparency/fda-basics
[4] FDA. Fda Patient Representative Program. Retrieved Oct 3, 2019 from https://www.fda.gov/patients/learn-about-fda-patient-engagement/about-fda-patient-representative-program
[5] EMA. EMA Basics. Retrieved Oct 3, 2019 from https://www.youtube.com/watch?v=UbWp2AYi_xM&feature=player_detailpage&list=PL7K5dNgKnawbH-EkoRxEGZ3iFD0ZMweCZ
[6] FDA. FDA rare disease listening sessions. Retrieved Oct 3, 2019 from https://www.fda.gov/patients/learn-about-fda-patient-engagement/patient-listening-sessions
[7] EMA. Patients' and Consumers' Working Party. Retrieved Oct 3, 2019 from https://www.ema.europa.eu/en/committees/working-parties-other-groups/chmp/patients-consumers-working-party
[8] FDA. Patient Engagement Collaborative. Retrieved Oct 3, 2019 from https://www.fda.gov/patients/learn-about-fda-patient-engagement/patient-engagement-collaborative
[9] FDA. For Patients. Retrieved Oct 3, 2019 from https://www.fda.gov/patients
[10] EMA. Committees. Retrieved Oct 3, 2019 from https://www.ema.europa.eu/en/committees/how-committees-work
*声明：本文由入驻新浪医药新闻作者撰写，观点仅代表作者本人，不代表新浪医药新闻立场。▽关注【药明康德】微信公众号
鐑瘝锛�
